SavedAdd your journal

Journals / Turkish Journal of Medical Sciences / 2018 / Cilt: 48 - Sayı: 3

Development and testing of a novel symptom assessment scale for Behçet’s disease

Filiz ÖZEL
Fisun ŞENUZUN AYKAR
Gökhan KESER
Aynur Esen TÜREYEN
Pages
491–502
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The validity and reliability study of the second section foundthat the scale had favorable fit indices (χ2 = 579.14, χ2 / SD = 3.48, GFI = 0.91, CFI = 0.89, IFI = 0.89) and constituted three dimensionsand 20 items.Conclusion: This novel symptom assessment scale for BD is a valid and reliable tool for evaluating patients with BD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: This study was designed to develop a Behçet’s disease (BD) symptom assessment scale based on the theory ofunpleasant symptoms, which deals with understanding symptom experiences in a disease.Materials and methods: The BD Symptom Assessment Scale has two sections: the factors influencing symptoms and the situationsinfluenced by symptoms.
📊
Key Findings & Data:Both of these sections were developed through an initial item pool, and expert opinions were consulted duringa pilot test performed with 30 patients with BD.
💡
Conclusion & Impact:The validity and reliability study of the second section foundthat the scale had favorable fit indices (χ2 = 579.14, χ2 / SD = 3.48, GFI = 0.91, CFI = 0.89, IFI = 0.89) and constituted three dimensionsand 20 items.Conclusion: This novel symptom assessment scale for BD is a valid and reliable tool for evaluating patients with BD.
🔬Design:Lab & Field Experiment
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: This study was designed to develop a Behçet’s disease (BD) symptom assessment scale based on the theory ofunpleasant symptoms, which deals with understanding symptom experiences in a disease.Materials and methods: The BD Symptom Assessment Scale has two sections: the factors influencing symptoms and the situationsinfluenced by symptoms. Both of these sections were developed through an initial item pool, and expert opinions were consulted duringa pilot test performed with 30 patients with BD. We then tested the validity and reliability of this scale on 218 different patients with BDfulfilling the ISG criteria. Finally, we scored this scale.Results: The validity and reliability study of the first section found that the scale had favorable fit indices (χ2 = 525.86, χ2 / SD = 3.15, GFI= 0.90, CFI = 0.89, IFI = 0.89), constituting three dimensions and 20 items. The validity and reliability study of the second section foundthat the scale had favorable fit indices (χ2 = 579.14, χ2 / SD = 3.48, GFI = 0.91, CFI = 0.89, IFI = 0.89) and constituted three dimensionsand 20 items.Conclusion: This novel symptom assessment scale for BD is a valid and reliable tool for evaluating patients with BD.

🔖

Cite This Article

ÖZEL, F., AYKAR, F. Ş., KESER, G., TÜREYEN, A. E. (2022). Development and testing of a novel symptom assessment scale for Behçet’s disease. Turkish Journal of Medical Sciences, Cilt: 48 - Sayı: 3, 491–502. https://ajindex.com/articles/610140

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Smith MJ, Liehr PR. Middle Range Theory for Nursing. 2nd ed. New York, NY, USA: Springer Publishing Company; 2008.
  2. Lenz ER, Suppe F, Gift AG, Pugh LC, Milligan RA. Collaborative development of middle-range nursing theories: toward a theory of unpleasant symptoms. Adv Nurs Sci 1995; 17: 1-13.
  3. Lenz ER, Pugh LC, Milligan RA, Gift A, Suppe F. The middlerange of theory of unpleasant symptoms: an update. Adv Nurs Sci 1997; 19: 14-27.
  4. Lee SE, Vincent C, Finnegan L. An analysis and evaluation of theory of unpleasant symptoms. Adv Nurs Sci 2017; 40: 16-39.
  5. Tyler R, Pugh LC. Application of the theory of unpleasant symptoms in bariatric surgery. Bariatr Nurs Surg Patient Care 2009; 4: 271-276. Reishtein JL. Relationship between symptoms and functional performance in COPD. Res Nurs Health 2005; 28: 39-47.
  6. Tsai YF, Hsiung PC, Holzemer WL. Symptom management in Taiwanese patients with HIV/AIDS. J Pain Symptom Manage 2002; 23: 301-309.
  7. Bernabe E, Marcenes W, Mather J. Impact of Behçet’s syndrome on health-related quality of life: influence of the type and number of symptoms. Rheumatology 2010; 49: 2165–2171.
  8. Blackford S, Finlay AY, Roberts DL. Quality of life in Behçet’s syndrome: 335 patients surveyed. Br J Dermatol 1997; 13: 293. Can G, Aydıner A. Development and validation of the Nightingale Symptom Assessment Scale (N-SAS) and predictors of the quality of life of the cancer patients in Turkey. Eur J Oncol Nurs 2011; 15: 3-11.
  9. Canpolat Ö, Yurtsever S. The quality of life in patients with Behçet’s disease. Asian Nurs Res 2011; 5: 229-235.
  10. De Vito Dabbs A, Hoffman LA, Swigart V. Using conceptual triangulation to develop an integrated model of experience of acute rejection after lung transplantation. Adv Nurs Sci 2004; 27: 138-149.
  11. Eren I, Şahin M, Cüre E, Çivi-İnanlı I, Tunç ŞE. Psychiatric symptoms and quality of life in Behçet’s disease. Neurol Psychiatry Brain Res 2006; 13: 169-174.
  12. Ertam I, Kitapçıoğlu G, Aksu, K. Quality of life and its relation with disease severity in Behçet’s disease. Clin Exp Rheumatol 2009; 27: 18-22.
  13. Gilworth G, Cahmberlain MA, Bhakta B, Haskard D, Silman A, Tennant A. Development of the BD-QOL: a quality of life measure specific to Behçet’s disease. J Rheumatol 2004; 31: 931-936.
  14. Gur A, Sarac AJ, Burkan YK, Nas K, Çevik R. Arthropathy, quality of life, depression, and anxiety in Behçet’s disease: relationship between arthritis and these factors. Clin Rheumatol 2006; 25: 524-531.
  15. Izuno T, Miyakawa M, Sugimori H. The effect of quality of life